Our November 2021
It’s called Long COVID, often Long-haul COVID and sometimes Post Acute Sequelae of COVID-19 (PASC). Last week the World Health Organisation announced a definition for what it calls “post COVID-19 condition”, affecting people at least two months after a COVID-19 infection with symptoms that cannot be explained by an alternative diagnosis.
Using learnings from ME/CFS studies, Long COVID research is bringing new hope of better diagnosis and treatment for both conditions
Up to an estimated 20% of people who survive COVID-19 will have persistent symptoms with no obvious organ damage. This is also known as post-COVID-19 syndrome, or Long COVID. The symptoms of Long COVID overlap with those of other post-infectious conditions like ME/CFS.
Long COVID research identifies Post-exertional Malaise (PEM), how exercise can be harmful and the need for pacing
The first principle of helping patients manage Long COVID, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), should be to do no harm. Patients and healthcare workers have tried to speed up recovery from Long COVID with exercise-based rehabilitation.
This paper identifies similar biological changes in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and acute COVID-19. The authors suggest that these changes may lead to what has become known as Long COVID, which also shares similarities with ME/CFS.
This global study asked Long COVID patients from 56 countries about their symptoms during the previous 7-months. Results revealed striking similarities between ME/CFS and Long COVID.
Search our site
Share on Social
Join our Newsletter
Giving a voice to the unseen and unheard.
Sign up to our newsletter today.